Regulacje i polityka gospodarcza · 21/11/2005

Medicare Program; Exclusion of Vendor Purchases Made Under the Competitive Acquisition Program (CAP) for Outpatient Drugs and Biologicals Under Part B for the Purpose of Calculating the Average Sales Price (ASP)

The Medicare program has issued an interim final rule with a comment period to clarify the relationship between drugs purchased under the Competitive Acquisition Program (CAP) and the calculation of Average Sales Price (ASP). The rule excludes units of CAP drugs from ASP calculations for up to 3 years, with the policy to be re-evaluated at that time.